These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27045418)

  • 21. [Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015].
    Hao D; Hu Z; Liu X; Sun T; Wang T; Tian H; Wang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):439-44. PubMed ID: 29920041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dynamic analysis of drug resistance of Pseudomonas aeruginosa in laboratory and clinical two-drug regimen].
    Tian BW; Yang YJ; Pang XY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1009-11. PubMed ID: 16109563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and resistance characteristics of Pseudomonas aeruginosa isolates from the respiratory department of a hospital in China.
    Feng W; Sun F; Wang Q; Xiong W; Qiu X; Dai X; Xia P
    J Glob Antimicrob Resist; 2017 Mar; 8():142-147. PubMed ID: 28216097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).
    Pfaller MA; Shortridge D; Sader HS; Castanheira M; Flamm RK
    Int J Antimicrob Agents; 2018 Feb; 51(2):181-189. PubMed ID: 28993143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
    Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
    J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The peculiarities of Pseudomonas aeruginosa resistance to antibiotics and prevalence of serogroups.
    Gailiene G; Pavilonis A; Kareiviene V
    Medicina (Kaunas); 2007; 43(1):36-42. PubMed ID: 17297282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The identification, typing, and antimicrobial susceptibility of Pseudomonas aeruginosa isolated from mink with hemorrhagic pneumonia.
    Qi J; Li L; Du Y; Wang S; Wang J; Luo Y; Che J; Lu J; Liu H; Hu G; Li J; Gong Y; Wang G; Hu M; Shiganyan ; Liu Y
    Vet Microbiol; 2014 Jun; 170(3-4):456-61. PubMed ID: 24629901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated in Fukushima Prefecture].
    Niitsuma K; Saitoh M; Kojimabara M; Kashiwabara N; Aoki T; Tomizawa M; Maeda J; Kosenda T
    Jpn J Antibiot; 2001 Feb; 54(2):79-87. PubMed ID: 11338681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
    Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A control study on bacterial resistance and clinical features of lower respiratory tract infection with Pseudomonas aeruginosa in medical intensive care unit and general ward].
    Shao C; Qu J; He L; Ni C; Hu B
    Zhonghua Nei Ke Za Zhi; 2002 Dec; 41(12):813-7. PubMed ID: 12654234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency and antibiogram of multi-drug resistant Pseudomonas aeruginosa.
    Gill MM; Usman J; Kaleem F; Hassan A; Khalid A; Anjum R; Fahim Q
    J Coll Physicians Surg Pak; 2011 Sep; 21(9):531-4. PubMed ID: 21914408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States.
    Sader HS; Huband MD; Castanheira M; Flamm RK
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069652
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated at Kochi Municipal Central Hospital in the last 3 years].
    Nasu Y; Abe M; Ono N; Araki M; Horimi T; Takahashi I
    Jpn J Antibiot; 2004 Oct; 57(5):438-48. PubMed ID: 15655905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbapenem-Resistant Pseudomonas aeruginosa Infection and Mixed Infections Are Risk Factors for Poor Outcome After Lung Transplant.
    Wu Y; Zhu J; Huang L; Li M; Cui X; Zhan Q; Wang C
    Exp Clin Transplant; 2024 Apr; 22(4):300-306. PubMed ID: 38742321
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Goodlet KJ; Nicolau DP; Nailor MD
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization by phenotypic and genotypic methods of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
    Li Y; Zhang X; Wang C; Hu Y; Niu X; Pei D; He Z; Bi Y
    Mol Med Rep; 2015 Jan; 11(1):494-8. PubMed ID: 25323940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in Germany.
    Seifert H; Körber-Irrgang B; Kresken M;
    Int J Antimicrob Agents; 2018 Feb; 51(2):227-234. PubMed ID: 28705666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
    Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
    Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.